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Introduction
Lafora disease (LD; OMIM #254780) is an autosomal recessive 
neurodegenerative disorder resulting in severe epilepsy and death 
(Lafora and Gluck, 1911; Van Hoof and Hageman-Bal, 1967). 
It is one of fi  ve major progressive myoclonus epilepsies. LD 
presents itself as a single seizure in the second decade of the 
patient’s life (Schwarz and Yanoff, 1965); this single event is 
followed by progressive central nervous system degeneration, 
culminating in death within 10 yr of the fi  rst seizure (Van Heycop 
Ten Ham, 1975). A hallmark of LD is the accumulation of poly-
glucosan inclusion bodies called Lafora bodies (LBs; Lafora, 
1911; Collins et al., 1968) that are located in the cytoplasm 
of cells in most organs (Harriman et al., 1955; Schwarz and 
Yanoff, 1965; Carpenter and Karpati, 1981). LB accumulation 
coincides with increased neuronal nonapoptotic cell death and a 
number of seizures in LD patients. Thus, it is hypothesized that 
LBs are responsible for these symptoms and, ultimately, for the 
death of the patient (Yokoi et al., 1968).
Recessive mutations in EPM2B (epilepsy of progressive 
myoclonus type 2 gene B)/NHLRC1 (Chan et al., 2003), which 
encodes the E3 ubiquitin ligase malin (Chan et al., 2003; Gentry 
et al., 2005), are responsible for  40% of LD cases (Ianzano et al., 
2005). Of the LD cases not attributed to mutations in EPM2B, 
 48% result from recessive mutations in EPM2A (epilepsy of pro-
gressive myoclonus type 2 gene A; Minassian et al., 1998; Serratosa 
et al., 1999; Ianzano et al., 2005). EPM2A encodes laforin, 
which contains a carbohydrate-binding module (CBM) family 20 
(CBM20; Wang et al., 2002) domain followed by the canonical dual 
specifi  city phosphatase (DSP) active site motif HCXXGXXRS/T 
(Cx5R) (Fig. 1 A; Denu et al., 1996; Yuvaniyama et al., 1996; 
Minassian et al., 1998). The CBM of laforin binds complex carbo-
hydrates in vivo and in vitro (Wang et al., 2002), and the DSP 
motif can hydrolyze phosphotyrosine and phosphoserine/threonine 
substrates in vitro (Ganesh et al., 2000; Wang et al., 2002). How-
ever, no group has detected endogenous laforin localization in tis-
sue culture cells or in wild-type tissues likely as a result of low 
levels of accumulation (Chan et al., 2004; our unpublished data).
The phosphatase laforin crosses evolutionary 
boundaries and links carbohydrate metabolism 
to neuronal disease
Matthew S. Gentry,
1,2,3 Robert H. Dowen III,
4 Carolyn A. Worby,
1,2,3 Seema Mattoo,
5 Joseph R. Ecker,
6 
and Jack E. Dixon
1,2,3,5
1Department of Pharmacology, 
2Department of Cellular and Molecular Medicine, 
3Department of Chemistry and Biochemistry, 
4Biomedical Sciences Graduate Program, 
and 
5The Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA 92093
6Plant Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037
  L
afora disease (LD) is a progressive myoclonic epilepsy 
resulting in severe neurodegeneration followed by 
death. A hallmark of LD is the accumulation of insolu-
ble polyglucosans called Lafora bodies (LBs). LD is caused 
by mutations in the gene encoding the phosphatase laforin, 
which reportedly exists solely in vertebrates. We utilized a 
bioinformatics screen to identify laforin orthologues in ﬁ  ve 
protists. These protists evolved from a progenitor red alga 
and synthesize an insoluble carbohydrate whose composi-
tion closely resembles LBs. Furthermore, we show that the 
kingdom Plantae, which lacks laforin, possesses a protein 
with laforin-like properties called starch excess 4 (SEX4). 
Mutations in the Arabidopsis thaliana SEX4 gene results in 
a starch excess phenotype reminiscent of LD. We demon-
strate that Homo sapiens laforin complements the sex4 
phenotype and propose that laforin and SEX4 are func-
tional equivalents. Finally, we show that laforins and SEX4 
dephosphorylate a complex carbohydrate and form the 
only family of phosphatases with this activity. These results 
provide a molecular explanation for the etiology of LD.
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Of the 128 human phosphatases (Zolnierowicz, 2000; Alonso 
et al., 2004), only laforin possesses a CBM. CBM domains are 
predominantly found in glucosylhydrolases and glucotransferases 
of bacterial, fungal, or plant origin (Coutinho and Henrissat, 
1999; Boraston et al., 2004; Rodriguez-Sanoja et al., 2005). The 
vast majority of enzymes containing a CBM use the domain to 
bind a specifi  c type of carbohydrate and then enzymatically act 
on the sugar (Boraston et al., 2004). Accordingly, we recently 
showed that laforin liberates phosphate from the complex carbo-
hydrate amylopectin, whereas other phosphatases lack this activity 
(Worby et al., 2006).
Ganesh et al. (2002) disrupted the EPM2A locus in a mouse 
model. Although this model faithfully recapitulated the disease, 
it yielded no molecular explanation for LD. Similarly, Chan et al. 
(2004) generated a transgenic mouse overexpressing inactivated 
laforin, and this mouse model also developed LD. Despite the 
availability of these two LD mouse models, the molecular etiol-
ogy of LD remained unexplained. These limitations demonstrate 
the need to develop alternative model systems to elucidate the 
biology of LD. Although a molecular mechanism to explain LD 
has remained elusive, data cumulatively place laforin in the con-
text of being intimately, if not directly, involved in regulating 
glycogen metabolism. Therefore, we focused on this indisput-
able aspect of LD for clues to its molecular etiology.
Insoluble glycogen, starch, 
and ﬂ  oridean starch
Glycogen is produced in the cytoplasm of the majority of ar-
chaebacterial, bacterial, fungal, and animal species. It is a water-
soluble polymer composed of α-1,4-glycosidic linkages between 
glucose residues, with branches occurring in a continuous pat-
tern every 12–14 residues via α-1,6-glycosidic linkages. Almost 
every study on LD refers to LBs as insoluble glycogen. How-
ever, defi  nitive biochemical studies on LBs found that the ar-
rangement and pattern of branching in LBs most closely resemble 
amylopectin (Yokoi et al., 1967, 1968; Sakai et al., 1970).
Amylopectin, like glycogen, is composed of α-1,4-glyco-
sidic linkages with α-1,6-glycosidic branches but with branches 
arranged in a discontinuous pattern every 12–20 residues. This 
discontinuous and decreased amount of branching renders amy-
lopectin insoluble. Amylopectin is one of the two components of 
starch, which is produced in the plastid of green plants (Viridae-
plantae). Starch is an insoluble, semicrystalline heterogeneous 
mixture of 10–25% amylose and 75–90% amylopectin. Plants 
synthesize starch in chloroplasts during daylight as a transient 
carbon store that is used during the dark cycle to generate a us-
able reduced form of carbon in the absence of photosynthesis.
Floridean starch is another insoluble carbohydrate that 
has similar biochemical properties to amylopectin (Peat et al., 
1959; Coppin et al., 2005). Floridean starch is synthesized in 
the cytoplasm of a variety of protists (i.e., unicellular eukary-
otes) and is used as an energy source during specifi  c stages of 
their life cycle. Floridean starch, like LBs and amylopectin, is 
made of glucose polymers with branches every 12–20+ resi-
dues in a discontinuous pattern (Coppin et al., 2005). Thus, 
fl  oridean starch, amylopectin, and LBs have been described as 
possessing similar characteristics.
Results
Discovery of laforin orthologues
One protist that accumulates fl  oridean starch (also called amy-
lopectin granules) in its cytoplasm is Toxoplasma gondii (Dubey 
et al., 1998; Coppin et al., 2005; Guérardel et al., 2005; for re-
view see Coppin et al., 2003). T. gondii is an obligate intracellu-
lar parasite that can infect nearly any nucleated cell from a 
warm-blooded animal. Like most members of Apicomplexa, 
T. gondii has a complex life cycle: in its intermediate hosts, it 
exists as a rapidly dividing tachyzoite or an encysted bradyzoite, 
depending on the host immune response. The bradyzoite forms 
fl  oridean starch in its cytoplasm that is used as an energy source 
(for review see Coppin et al., 2003). Recent studies character-
ized the biochemical composition of T. gondii fl  oridean starch 
(Coppin et al., 2005; Guérardel et al., 2005). We noted that 
the biochemical composition of T. gondii fl  oridean starch was 
remarkably similar to that of LBs described nearly 40 yr ago 
(Yokoi et al., 1967, 1968; Sakai et al., 1970). Although EPM2A 
has been reported to be present only in vertebrates (Ganesh et al., 
2001, 2004), the similarity between T. gondii fl  oridean starch and 
LBs led us to explore the partially completed T. gondii genome 
for a laforin orthologue.
The sequence of the T. gondii genome, like the genome of 
many protists, was not accessible via GenBank when we initi-
ated this study. Therefore, we searched the T. gondii database 
(ToxoDB; Kissinger et al., 2003) for a laforin orthologue. We 
used the criteria that a laforin orthologue must contain both 
an amino-terminal CBM and a carboxy-terminal DSP domain 
(Fig. 1 A). DSP domains are readily recognized by the protein 
families database (pfam; Bateman et al., 2004) and the National 
Center for Biotechnology Information’s (NCBI) conserved 
domain database (CDD; Marchler-Bauer et al., 2005). However, 
CBMs are very degenerate at the primary amino acid level, and 
neither database consistently recognizes any of the 45 CBM 
families. Because CDD and pfam do not reliably recognize CBMs, 
we devised a multitiered search strategy to identify laforin ortho-
logues (Fig. 1 B). First, we performed BLASTp (Altschul et al., 
1997) searches using the DSP motif HCXXGXXR as an index 
sequence and identifi  ed 20 T. gondii proteins containing this 
motif. Because laforin contains an amino-terminal CBM and 
CBMs contain 80–100 amino acids, we eliminated two of these 
proteins because their HCXXGXXR motif was within the fi  rst 
80 amino acids. We next performed a secondary BLAST using 
the NCBI nonredundant (nr) database with each of the remain-
ing 18 proteins minus their DSP domain. If the protein contained 
a CBM, the BLAST identifi  ed other CBM-containing proteins. 
Using this strategy, we identifi  ed one protein, which we refer to 
as T. gondii laforin (Tg-laforin), that met the aforementioned 
criteria. Tg-laforin and Homo sapiens laforin (Hs-laforin) are 
37% identical (Fig. 1 C). Importantly, Tg-laforin contains all of 
the residues important for carbohydrate binding as well as the 
signature residues of a DSP (Fig. 1 A).
With the discovery of a putative laforin orthologue in 
T. gondii, we extended our search methods to identify additional 
orthologues using a variety of genome databases (Table S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). LAFORIN LINKS SUGAR METABOLISM TO NEURONAL DISEASE • GENTRY ET AL. 479
Using this strategy, we identifi  ed laforin orthologues in the four 
classes of vertebrates with sequenced genomes (mammals, aves, 
amphibians, and osteichthyes; Fig. 1, A and D). In addition, we 
identifi  ed putative laforin orthologues in four additional protists: 
Eimeria tenella, Tetrahymena thermophila, Paramecium tetrau-
relia, and Cyanidioschyzon merolae (Fig. 1, A and C). Although 
Hs-laforin contains 331 amino acids, the putative protist ortho-
logues varied in predicted size from 323 to 727 amino acids. 
However, each putative orthologue contained the signature amino 
acids of a CBM20 and DSP; that is, four invariant aromatic 
amino acids (Hs-laforin F5, W32, W60, and W99) as well as 
DX30CX2GX2R, respectively (Fig. 1 A). Despite exhaustive 
efforts (we searched  170 eukaryotic genomes and  670 bac-
terial and archaeal genomes), we did not identify any other pu-
tative laforin orthologues. Thus, laforin is absent in all traditional 
nonvertebrate model organisms (e.g., yeast, fl  y, and worms). 
Laforin orthologues exist in all classes of vertebrates in which 
sequence data is available and in the fi  ve protists that we identi-
fi  ed (Fig. 1, A, C, and D).
Biochemical properties and subcellular 
localization of laforin orthologues
C. merolae laforin (Cm-laforin) shares the least identity with 
Hs-laforin (Fig. 1 C). As such, we reasoned that if it exhibited 
similar in vitro characteristics as Hs-laforin, the other putative 
orthologues were likely to as well. To test whether the identi-
fi  ed protist proteins had similar biochemical characteristics as 
Hs-laforin and were thus laforin orthologues, we cloned the 
putative orthologue from C. merolae (Cm-laforin) and purifi  ed 
recombinant protein from bacteria (Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200704094/DC1). Characteristic 
of all DSPs, Hs-laforin exhibits phosphatase activity against 
the artifi  cial substrate para-nitrophenylphosphate (p-NPP; Fig. 
2 A; Ganesh et al., 2000). Cm-laforin also used p-NPP as an 
artifi  cial substrate with similar kinetics as Hs-laforin (Table I) 
and displayed a similar specifi  c activity (Fig. 2 A). In addition 
to activity against p-NPP, we recently showed that recombinant 
Hs-laforin releases phosphate from amylopectin (Worby et al., 
2006) and that this activity is unique to laforin (Worby et al., 
2006). Additionally, we fused the CBM of laforin to the DSP 
VH1 related (VHR) and demonstrated that although this fusion 
protein was an active phosphatase, it did not liberate phosphate 
from amylopectin (Worby et al., 2006). Fig. 2 B shows that like 
Hs-laforin, Cm-laforin displays a robust ability to release phos-
phate from amylopectin, whereas VHR does not hydrolyze 
phosphate from amylopectin. As predicted, the catalytically in-
active Cm-laforin–C/S mutant displayed no activity against 
either substrate (Fig. 2, A and B). Additionally, Tg-laforin also 
displayed activity against both p-NPP and amylopectin (unpub-
lished data).
Hs-laforin is the only phosphatase in the human genome that 
contains a CBM and, as such, is predicted to be the only phospha-
tase that binds carbohydrates. Cm-laforin and Tg-laforin bound 
amylopectin to the same extent as Hs-laforin (Fig. 2 C and not 
depicted). Conversely, VHR did not bind amylopectin (Fig. 2 C). 
Wang et al. (2002) previously demonstrated that conserved trypto-
phan and lysine residues (Fig. 1 A) that participate in binding to the 
sugar are necessary for Hs-laforin to bind amylopectin (Fig. 2 C). 
Figure 1. Laforin  orthologues.  (A) An alignment of the vertebrate and protist laforin orthologues. Residues highlighted in red are highly conserved CBM20 
residues as deﬁ  ned by the CBM20 family (Wang et al., 2002), residues boxed in red are invariant CBM20 residues (Wang et al., 2002), and residues 
boxed in blue are part of the DSP catalytic site. Residues boxed in dark gray are identical, and those boxed in light gray are conserved substitutions. Aster-
isks mark residues that are necessary for binding to carbohydrates (Wang et al., 2002). Accession numbers are listed in Table S2 (available at http://
www.jcb.org/cgi/content/full/jcb.200704094/DC1). (B) Strategy to identify laforin orthologues in T. gondii. (C) Percent similarity and identity of full-
length Hs-laforin and both domains compared with those of protists. (D) Percent similarity and identity of full-length Hs-laforin and both domains compared 
with those of other vertebrates.JCB • VOLUME 178 • NUMBER 3 • 2007  480
Accordingly, mutation of these corresponding residues in Cm-
laforin also abolished its ability to bind amylopectin (Fig. 2 C). 
These mutations also considerably reduced the ability of Cm-
laforin to release phosphate from amylopectin (Fig. S2 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1) 
while only minimally affecting its p-NPP activity (Fig. S2 B). 
These data suggest that Cm-laforin must be positioned correctly 
via the CBM in order for the DSP domain to dephosphorylate 
amylopectin or that the CBM binding to the carbohydrate is 
needed to activate the DSP.
While laforin from all three species binds α-glucans 
in vitro, this result may not refl  ect the biological localization of 
laforin. Moreover, the localization of Hs-laforin has never been 
determined in wild-type cells or tissues (Chan et al., 2004; our 
unpublished data). Because we identifi  ed multiple new systems to 
study laforin, we investigated laforin’s localization in C. merolae. 
A C. merolae cell contains a chloroplast, mitochondrion, and 
nucleus and, when grown in continuous light, accumulates vast 
storages of fl  oridean starch (Fig. 2 D, schematic; Viola et al., 
2001). We fi  xed C. merolae cells and probed them with an affi  nity-
purifi  ed α–Cm-laforin antibody. We found that endogenous 
Cm-laforin localized in punctate accumulations throughout the 
cytoplasm of cells (Fig. 2 D). To further defi  ne the localization 
of Cm-laforin, we performed immunogold electron microscopy 
staining. Ultra-thin sections of C. merolae cells were probed with 
the affi  nity-purifi  ed α–Cm-laforin antibody and a 10-nm gold 
particle–conjugated goat α–rabbit secondary antibody. Positive 
staining was observed surrounding the fl  oridean starch granules 
Figure 2.  Biochemical characterization of laforin orthologues. (A) Speciﬁ  c activity of VHR, Hs-laforin, Hs-laforin–C/S, Cm-laforin, and Cm-laforin–C/S 
against p-NPP at their respective optimal pH. WT, wild type. (B) Phosphate release measured by malachite green assays using VHR, Hs-laforin, Hs-laforin–
C/S, Cm-laforin, and Cm-laforin–C/S against amylopectin at their respective optimal pH. (A and B) Error bars indicate mean ± SD. (C) Recombinant histidine-
tagged proteins were incubated with 5 mg/ml amylopectin, amylopectin was pelleted by ultracentrifugation, and proteins in the pellet (P) and supernatant (S) 
were visualized by Western analysis as described. VHR, H. sapiens VHR; Hs, Hs-laforin; Cm, Cm-laforin. Mutated residues are marked with an asterisk in 
Fig. 1 A. (D) A schematic of a nondividing C. merolae cell, deﬁ  ning the position of the chloroplast, mitochondrion, nucleus, and ﬂ  oridean starch. Cells were 
ﬁ  xed, incubated with preimmune serum (left) or α–Cm-laforin antibody (right), and probed with a FITC-conjugated α–rabbit secondary antibody. Chloro-
plasts were visualized via their autoﬂ  uorescence. (E) C. merolae cells were sectioned, probed with α–Cm-laforin and α–rabbit 10 nM gold-conjugated sec-
ondary antibodies, and visualized at 6,000× magniﬁ  cation. The arrow deﬁ  nes the chloroplast, asterisks mark the distal ends of a mitochondrion, and 
arrowheads mark three (of the many) ﬂ  oridean starch granules. Bars (D), 3 μm; (E) 500 nm.
Table I. Kinetics of laforin orthologues and SEX4 utilizing p-NPP
Vmax kcat km kcat/km
Hs-laforin 3.79 μmol min
−1 mg
−1 2.41 s
−1 0.323 mM 7451 s
−1 M
−1
Cm-laforin 13.05 μmol min
−1 mg
−1 12.62 s
−1 1.165 mM 10832 s
−1 M
−1
SEX4 2.41 μmol min
−1 mg
−1 1.54 s
−1 0.410 mM 3756 s
−1 M
−1
Kinetics of Hs-laforin, Cm-laforin, and A. thaliana ∆52-SEX4 (SEX4) utilizing p-NPP at pH 5.5, pH 6.0, and pH 6.0, respectively. Vmax is the maximum velocity of 
phosphate release from the substrate. Kcat is the catalytic constant of the phosphate-releasing reaction (equal to the turnover number). Km is the apparent equilibrium 
constant (the substrate concentration when the rate is at half of Vmax).LAFORIN LINKS SUGAR METABOLISM TO NEURONAL DISEASE • GENTRY ET AL. 481
(Fig. 2 E, arrowheads). No Cm-laforin was observed within 
the granules because before sectioning, no protein would have 
access to this region. In addition, no background staining was 
observed with the secondary antibody alone (Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). Thus, 
as we hypothesized, endogenous laforin binds the outer region 
of insoluble carbohydrates.
Cm-laforin and Tg-laforin possess the same three in vitro 
properties as Hs-laforin: both use p-NPP as an artifi  cial substrate, 
bind amylopectin, and release phosphate from amylopectin. 
Accordingly, the laforin orthologues in vertebrates and the fi  ve 
mentioned protists contain the critical signature primary amino 
acid structure of a CBM20 and DSP. Thus, our integrated bio-
informatics searches for combined CBM and DSP domains cor-
rectly predicted the biochemical properties of Cm-laforin. Because 
the laforin orthologues are the only proteins in any of these ge-
nomes that contain a CBM and DSP, we hypothesized that these 
organisms may have acquired laforin from a common ancestor.
Evolutionary lineage of laforin
The key to the evolutionary lineage of laforin lies in the origin of 
the aforementioned fi  ve protists. The chromalveolate hypothesis 
postulates (Cavalier-Smith, 1999) that a distinct sequence of events 
led to the evolution of the kingdom Plantae and to subsequent 
progeny, including the fi  ve aforementioned protists. As illustrated 
in Fig. 3 A, a mitochondriate protist engulfed a cyanobacterium 
(Cavalier-Smith, 1982; Bhattacharya and Medlin, 1998) and even-
tually gave rise to the kingdom Plantae (Cavalier-Smith, 2004). 
Once Plantae was established, a second endosymbiosis involving 
red algae (Gillott and Gibbs, 1980) gave rise to the chromalveo-
lates (Fig. 3 B; Cavalier-Smith, 1999). These engulfments were 
accompanied with the coevolution of “various manifestations of 
mitochondria” (Embley and Martin, 2006) and various forms of 
carbohydrate storage (Viola et al., 2001). These combined evolu-
tionary events resulted in organisms possessing a mitosome, a 
hydrogenosome, or a true mitochondrion, and some organisms 
evolved fl  oridean starch as their storage carbohydrate. We hypoth-
esized that interspersed within these evolutionary events, organisms 
maintained, gained, or lost laforin.
To trace the lineage of laforin, we generated a phylogeny 
derived from the small subunit ribosomal RNA gene of orga-
nisms belonging to diverse evolutionary niches and highlighted 
the organisms whose genome contains laforin (Fig. 3 C). This 
phylogenetic analysis revealed that each of the fi  ve protists con-
taining a laforin orthologue is of red algal descent. However, 
the genome of some organisms of red algal descent lack lafo-
rin (Fig. 3 C). To determine why some organisms of red algal 
descent lack laforin, we analyzed the biology of each of the 
organisms in Fig. 3 C. We discovered that each organism of 
red algal descent that contained laforin also contained a true 
mitochondrion and produced fl  oridean starch. Conversely, orga-
nisms of red algal descent lacking laforin either lacked a true 
Figure 3.  Evolutionary lineage of laforin. (A) 
Primary endosymbiosis hypothesized by the chro-
malveolate hypothesis (Cavalier-Smith, 1999). A 
cyanobacterium (CB) was engulfed by a mitochon-
driate protist (Cavalier-Smith, 1982; Bhattacharya 
and Medlin, 1998). MT, mitochondrion. Over 
generations, gene transfer occurred between the 
engulfed cyanobacterium and protist, the cyano-
bacterium was reduced to a plastid bound by two 
membranes, and the plastid-containing protist radi-
ated into the founding members of the kingdom 
Plantae (Cavalier-Smith, 2004). (B) Secondary 
endosymbiosis hypothesized by the chromalveo-
late hypothesis (Cavalier-Smith, 1999). A red alga 
(RA) was engulfed by a mitochondriate protist 
(Gillott and Gibbs, 1980). Over generations, gene 
transfer occurred from the red alga nucleus and 
plastid to the nucleus of the protist, the red alga was 
reduced to a plastid bound by three or four mem-
branes, and the new protist radiated into the kingdom 
Chromista and the alveolates, which are collec-
tively referred to as the chromalveolates (Cavalier-
Smith, 1999). The ﬁ  gure expands on the work of 
Weber et al. (2006). (C) Conservation of laforin 
orthologues. A phylogeny of the small subunit ribo-
somal RNA sequences was generated as described 
in Materials and methods, and accession numbers 
are listed in Table S3 (available at http://www.jcb
.org/cgi/content/full/jcb.200704094/DC1). Or-
ganisms containing laforin are boxed in yellow. 
Organisms from green algal descent are in green, 
organisms from glaucophyte descent are in blue, 
and organisms from red algal descent are in red. 
Alveolates are shaded with a gray background.JCB • VOLUME 178 • NUMBER 3 • 2007  482
mitochondrion or did not produce fl  oridean starch. For example, 
Plasmodium falciparum is of red algal descent and possesses 
mitochondria; however, it does not produce fl  oridean starch 
and, thus, lacks laforin (Fig. 3 C). Similarly, Cryptosporidium 
parvum is of red algal descent and produces fl  oridean starch, 
but it has mitosomes instead of mitochondria and, thus, lacks 
laforin (Fig. 3 C). Conversely, C. merolae is a red alga that 
produces fl  oridean starch and contains a single mitochondrion 
and, in agreement with our established criteria, contains laforin. 
Additionally, glaucophytes and green algae/land plants lack a 
laforin orthologue because they evolved as contemporaries of 
red algae and not as descendents (Fig. 3 A). Thus, our analyses 
generated three criteria to predict whether a protist’s genome 
possesses laforin: the organism must (1) be of red algal descent, 
(2) possess a true mitochondrion, and (3) produce fl  oridean 
starch. To determine whether our criteria correctly predicted the 
presence of laforin, we investigated the biology of each organ-
ism from the 168 eukaryotic genomes we probed. We found 
that in each case, our criteria correctly predicted the presence 
or absence of laforin (Table S5, available at http://www.jcb
.org/cgi/content/full/jcb.200704094/DC1).
A laforin-like protein in plants
Protists such as T. gondii use insoluble fl  oridean starch as an 
energy source when transitioning from inactive/hibernating life 
cycle stages to active/replicative stages (for review see Coppin 
et al., 2003). Likewise, C. merolae, a red alga that contains 
laforin, synthesizes insoluble fl  oridean starch during the day 
and uses it as a source of energy at night. Plants have a similar 
diurnal cycle, producing insoluble carbohydrate in the form 
of starch during the day and catabolizing it during the night. 
Because Hs-laforin has been implicated in carbohydrate metab-
olism and we show that Cm-laforin binds and releases phos-
phate from amylopectin, we hypothesized that laforin plays a 
vital role in insoluble carbohydrate metabolism. Thus, we pre-
dicted that plants would also have a laforin-like activity; how-
ever, we were unable to identify a laforin orthologue in plants. 
Recently, several starch excess mutants that accumulate starch 
have been described in plants (Blennow et al., 2002; Smith et al., 
2005; Zeeman et al., 2007); one of these is attributed to mu-
tations in the starch excess 4 (SEX4) gene (At3g52180; Niittyla 
et al., 2006). Niittyla et al. (2006) and Kerk et al. (2006) dem-
onstrated that the Arabidopsis thaliana SEX4 gene (previously 
identifi  ed as a phosphatase and called AtPTPKIS1; Fordham-
Skelton et al., 2002) encodes a protein containing a  chloroplast-
targeting peptide (cTP) and DSP domain at its amino terminus 
followed by a CBM-like domain at its carboxy terminus (Fig. 
4 A), suggesting that SEX4 might be a laforin-like phosphatase 
(Niittyla et al., 2006).
The DSP of SEX4 shares the key DX30CX2GX2R catalytic 
residues with the DSP of Hs-laforin and is 24% identical to 
Hs-laforin (Fig. 4, B and D). Conversely, the CBM of SEX4 
lacks many of the invariant CBM20 residues (Figs. 4 C vs. 1 A) 
and shares only 18% identity with the CBM of Hs-laforin (Fig. 4 D). 
Instead, a sequence search using the CBM of SEX4 shows that 
it is most similar to another class of CBM, the AMP-activated 
protein kinase β–glycogen-binding domain (AMPKβ−GBD) 
family (Polekhina et al., 2003), and not to CBM20 (Fig. 4, 
C and D). Despite their structural differences, both CBM20 and 
the AMPKβ-GBD domains interact with individual glycan chains 
of carbohydrates (Boraston et al., 2004; Polekhina et al., 2005), 
suggesting that SEX4 could bind starch via its AMPKβ-GBD. 
Thus, SEX4 contains similar domains to laforin, but the domains 
are arranged in the opposite orientation (Figs. 1 A vs. 4 A). We 
next performed BLASTp searches of various databases (Table 
S1) and found that SEX4 is conserved in all land plants and in 
Chlamydomonas reinhardtii, a single-cell green alga closely 
related to the progenitor of land plants (Fig. 4, C and D). Thus, 
SEX4 likely evolved before or during the establishment of green 
algae and performs a kingdom-wide function in Plantae.
To ascertain whether SEX4 possesses biochemical prop-
erties similar to laforin, we cloned A. thaliana SEX4 and assayed 
purified recombinant SEX4 protein (At-SEX4; Fig. S1 B). 
Because the cTP of SEX4 is highly hydrophobic and renders the 
protein insoluble, we deleted the fi  rst 52 amino acids and used 
purifi  ed recombinant HIS-tagged ∆52-SEX4 for our assays (Fig. 
S1 B). We found that ∆52-SEX4 has a similar specifi  c activity 
and possesses similar kinetics as Hs-laforin against p-NPP (Fig. 
4 E and Table I) and effi  ciently liberates phosphate from amylo-
pectin (Fig. 4 F). Conversely, mutation of the active site cysteine 
to serine abolished these activities (Fig. 4, E and F). Additionally, 
wild-type (∆52-SEX4) and catalytically inactive SEX4 (∆52-
SEX4-C198S) bind amylopectin similar to Hs-laforin (Fig. 4 G). 
Importantly, mutations in key conserved AMPKβ-GBD residues 
that form essential hydrogen bonds with the sugar (Polekhina 
et al., 2003, 2005) abolish this interaction (Fig. 4 G) while mini-
mally affecting the phosphatase activity of SEX4 (Fig. S4 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). 
These mutations considerably reduced the ability of SEX4 to 
release phosphate from amylopectin (Fig. S4 B). Thus, like Cm-
laforin, SEX4 must also be positioned correctly via the CBM in 
order for the DSP domain to dephosphorylate amylopectin.
Clearly, SEX4 and the laforins contain both a functional 
CBM and a DSP domain highly specifi  c for dephosphorylating 
amylopectin. Additionally, we speculate that they are involved 
in insoluble carbohydrate metabolism. Because carbohydrate 
metabolism evolved independently in the kingdom Plantae and 
kingdom Animalia, the use of similar protein modules to regu-
late a key feature of carbohydrate metabolism in these lineages 
is a striking example of convergent evolution and strongly sug-
gests that laforin and SEX4 might be functional equivalents.
SEX4 is a functional equivalent of laforin
The SEX4 locus was recently mapped in A. thaliana to At3g52180, 
and multiple mutations in this gene display a starch excess pheno-
type (Niittyla et al., 2006; Sokolov et al., 2006). One character-
ized mutation is the sex4-3 allele that contains an Agrobacterium 
transferred DNA (T-DNA) insertion in the sixth exon (Niittyla 
et al., 2006) and leads to the disruption of SEX4 expression (Fig. 
5 A). Because laforin and SEX4 are the only reported proteins 
in any kingdom that contain both functional CBM and DSP 
domains and because mutations in the gene expressing either 
protein results in aberrant carbohydrate accumulation, we postu-
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To test this hypothesis, we transformed sex4-3 plants to 
generate stable lines expressing SEX4, sex4-C/S, Hs-laforin, 
and Hs-laforin fused behind a cTP (cTP–Hs-laforin) to target 
Hs-laforin to the chloroplast (like SEX4) and monitored protein 
expression of the transgenes (Fig. 5 B). We then assayed starch 
accumulation in wild-type, sex4-3, and sex4-3 transgenic plants. 
As per our prediction, transformants expressing SEX4 and 
cTP–Hs-laforin no longer displayed the starch excess pheno-
type, whereas the catalytically inactive sex4-C/S mutant and 
Hs-laforin transformants still accumulated excess starch (Fig. 5, 
C and D; and Fig. S5, available at http://www.jcb.org/cgi/ 
content/full/jcb.200704094/DC1). Thus, the cTP–Hs-laforin 
fusion rescued the starch excess phenotype both qualitatively and 
quantitatively. Conversely, Hs-laforin lacking the cTP did not 
rescue any portion of the phenotype. Therefore, Hs-laforin is a 
functional equivalent of SEX4 that must be targeted to the chlo-
roplast, just like SEX4, to perform the equivalent function.
Discussion
Our studies probe the molecular mechanism of LD. We identi-
fi  ed laforin orthologues in specifi  c protists and further showed 
that Hs-laforin and plant SEX4 are functional equivalents. 
Our results provide compelling evidence that a laforin-like 
 activity is required to regulate the metabolism of amylopectin-like 
material across multiple kingdoms. Additionally, they demonstrate 
the nature of this activity; that is, the dephosphorylation of the 
carbohydrate itself, thus providing a molecular explanation for 
LD. Although there are examples of DSPs that dephosphorylate 
nonproteinacious substrates (such as phosphate and tensin homo-
logue, the myotubularin family, and Sac domain phosphatases 
that dephosphorylate the inositol head group of phospholipids; 
Chung et al., 1997; Maehama and Dixon, 1998; Guo et al., 1999; 
Hughes et al., 2000; Taylor et al., 2000; Robinson and Dixon, 
2006), ours is the fi  rst example of a family of phosphatases that 
dephosphorylate complex carbohydrates.
We demonstrate that laforin is not merely restricted to the 
genomes of vertebrates but is well conserved in the protists 
T. gondii, E. tenella, T. thermophila, P. tetraurelia, and C. merolae. 
Laforin’s evolutionary lineage shows that it originated in a 
primitive red alga during early eukaryotic evolution. Despite 
its early origin, laforin was only maintained by organisms that 
synthesize fl  oridean starch (such as the aforementioned fi  ve 
protists) and organisms that inhibit the production of insoluble 
carbohydrates (i.e., all vertebrates). Organisms that no longer 
performed either of these processes lost laforin. Conversely to 
Figure 4.  Conservation and biochemical properties of SEX4. (A) Domain topography of SEX4. cTP, chloroplast-targeting peptide; DSP, dual speciﬁ  c 
phosphatase; GBD, glycogen-binding domain. (B) Alignment of the DSP of Hs-laforin (Hs-DSP) and the DSP of SEX4 (At-DSP). Residues boxed in blue are 
part of the DSP catalytic site, those boxed in dark gray are identical, and those boxed in light gray are conserved substitutions. (C) Alignment of the 
AMPKβ-GBD of four founding members of the family (top four, marked by a bracket; Polekhina et al., 2003) and the AMPKβ-GBD of SEX4 orthologues. 
Residues boxed in orange are highly conserved amino acids among multiple AMPKβ-GBD (Polekhina et al., 2003) proteins. Residues boxed in dark gray 
are identical, and those boxed in light gray are conserved substitutions. Asterisks mark residues necessary for carbohydrate binding (Polekhina et al., 
2003, 2005). Accession numbers are listed in Table S5 (available at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). (D) Percent similarity 
and identity of full-length At-SEX4 compared with SEX4 orthologues, the DSP of Hs-laforin to the DSP of each SEX4 orthologue, and the CBM20 of Hs-laforin 
to the glycogen-binding domain (GBD) of each SEX4 orthologue as well as the percent similarity of the GBD of Hs-AMPKβ1 to the glycogen-binding 
domain of each SEX4 orthologue. (E) Speciﬁ  c activity of VHR, Hs-laforin, Hs-laforin–C/S, ∆52-SEX4, and ∆52-SEX4-C/S against p-NPP at their respective 
optimal pH. (F) Phosphate release measured by malachite green assays using VHR, Hs-laforin, Hs-laforin–C/S, ∆52-SEX4, and ∆52-SEX4-C/S against 
amylopectin at their respective optimal pH. (E and F) Error bars indicate mean ± SD. (G) At-SEX4 binding to amylopectin. Recombinant histidine-tagged 
proteins were incubated with 5 mg/ml amylopectin, amylopectin was pelleted by ultracentrifugation, and proteins in the pellet (P) and supernatant (S) 
were visualized by Western analysis as described. ∆52-SEX4, amino-terminal truncation of SEX4; C198S, ∆52-SEX4-C198S; N333K, ∆52-SEX4-N333K; 
K307Q, ∆52-SEX4-K307Q.JCB • VOLUME 178 • NUMBER 3 • 2007  484
laforin, we show that although SEX4 contains similar domains 
as laforin, its lineage differs in that SEX4 is conserved in all 
land plants as well as in C. reinhardtii, a close descendent of 
primitive green algae. Despite their different lineages, Hs-laforin 
performs the same function as the plant protein SEX4; thus, we 
propose that laforin and SEX4 are functional equivalents.
It must be noted that although laforin and SEX4 share a 
common function and similar domains, they are not orthologous 
proteins. They are not orthologues because (1) although they 
share similar CBMs, the CBMs belong to different classes and 
differ considerably with respect to the primary amino acids that 
are important for binding carbohydrates, and (2) the DSP and 
CBM of laforin and SEX4 are arranged in opposite orientations. 
Thus, it is likely that red and green algae independently evolved 
a phosphatase via convergent evolution that utilizes a similar 
mechanism to regulate insoluble carbohydrate metabolism.
Despite the independent means by which laforin and 
SEX4 evolved, they both dephosphorylate the same carbo-
hydrate substrate and constitute a unique family of phosphatases. 
In addition, we demonstrate that endogenous Cm-laforin local-
izes around the fl  oridean starch granules. Although most studies 
thus far suggest a carbohydrate substrate for laforin and SEX4, 
it is possible that they bind their respective amylopectin-like 
material (insoluble glycogen and starch, respectively) and 
dephosphorylate a proteinacious substrate. This proteinacious 
substrate would likely be involved in regulating carbohy-
drate metabolism, a process controlled by multiple levels of 
phosphorylation (Roach, 2002). Although the overall carbo-
hydrate machinery differs substantially between mammals and 
plants, both systems contain common phosphoproteins that 
share conserved functions (Preiss et al., 1983; Vikso-Nielsen 
et al., 2002; Coppin et al., 2005). These proteins would be likely 
substrate candidates for laforin and SEX4. To address this hy-
pothesis, we tested the majority of the mammalian candidates, 
but none of them served as a substrate for laforin (Worby et al., 
2006; our unpublished data).
It is interesting that laforin and SEX4 are functional equiv-
alents that dephosphorylate a complex carbohydrate and that 
the mutation of either gene results in the accumulation of insol-
uble carbohydrates in vertebrates and plants, respectively. Our 
understanding of the metabolism of insoluble carbohydrates 
in vertebrate systems is still in its infancy. In contrast, the plant 
Figure 5.  Hs-laforin is a functional equivalent of sex4. (A) sex4-3 disruption and gene expression. A schematic of the At3g51280 locus with exons repre-
sented by dark gray boxes, the T-DNA insertion depicted as a black arrowhead, and a schematic of the SEX4 protein. Small arrows denote the primer sets 
used to conﬁ  rm the absence of a SEX4 transcript in sex4-3 plants. RT-PCR results from wild-type and sex4-3 isolated mRNA. Lane 1, primer set 1 from the 
schematic; lane 2, primer set 2; lane 3, the 5′ primer from 1 and the 3′ primer from 2. The arrow indicates the size of the positive control UBC5. (B) Protein 
expression of transgenes. Tissue samples for Western analysis were taken from two independent T2 plants transformed with empty vector or an HA epitope–
tagged transgene as indicated. 30 mg of whole tissue lysate was loaded in each lane. (C) Complementation of the starch excess phenotype. One leaf from 
the same two independent T2 plants as in Fig. 4 B were decolorized with hot ethanol and stained with iodine. Wild-type (WT) leaves contain little starch 
and do not stain; conversely, sex4-3 leaves contain high amounts of starch and are darkly stained. Similarly, transgenes that complement the phenotype do 
not stain, whereas those that do not complement stain dark. (D) Quantitation of the complementation. Starch was quantiﬁ  ed from leaves of wild-type, sex4-3, 
and sex4-3 transgenic plants. Each sample is the mean of replicate samples ± standard error. For sex4-3 transgenic plants, six independent T2 plants 
  isogenic to those used in Fig. 4 (B and C) were used to quantitate the amount of starch in leaves. FW, fresh weight.LAFORIN LINKS SUGAR METABOLISM TO NEURONAL DISEASE • GENTRY ET AL. 485
community has made substantial progress in understanding the 
metabolism of starch (Smith et al., 2005; Zeeman et al., 2007). 
In plants, it is clear that the phosphorylation of glucose residues 
within starch is required for its proper accumulation and degra-
dation (Blennow et al., 2002; Smith et al., 2005; Zeeman et al., 
2007). In A. thaliana, glucan water dikinase (Ritte et al., 2002) 
and phosphoglucan water dikinase (Baunsgaard et al., 2005; 
Kotting et al., 2005) phosphorylate glucose monomers within 
amylopectin at the C6 and C3 position (Ritte et al., 2006), re-
spectively. As with SEX4, mutations in the genes encoding glu-
can water dikinase and phosphoglucan water dikinase also yield 
a starch excess phenotype (Yu et al., 2001; Baunsgaard et al., 
2005; Kotting et al., 2005). Phosphorylation is necessary for 
both starch accumulation and degradation; however, the timing 
of these phosphorylation and dephosphorylation events is un-
known (Smith et al., 2005; Zeeman et al., 2007). Intriguingly, 
although glycogen, the soluble storage carbohydrate in verte-
brates, contains little to no phosphate, detrimental insoluble 
carbohydrates like LBs are highly phosphorylated, just like am-
ylopectin in plant starch (Schnabel and Seitelberger, 1968; Sakai 
et al., 1970). Therefore, it appears logical that laforin and SEX4 
evolved to perform the critical role of dephosphorylating 
insoluble carbohydrates to allow their proper degradation.
This basic function of insoluble carbohydrate metabolism 
provides an intriguing explanation for both the existence of a 
laforin-like activity in protists and plants and the role of laforin 
in preventing LD. In protists and plants, carbohydrate dephos-
phorylation would be necessary for the utilization of insoluble 
carbohydrates as an energy source. When this activity is absent, 
these organisms accumulate unusable starch as in the sex4 
mutants. In vertebrates, laforin would dephosphorylate nascent 
insoluble carbohydrates to inhibit the formation of detrimental 
LBs. In the absence of laforin, these nascent molecules increase 
in size and number and eventually cause LD.
Our work clearly demonstrates that a laforin-like activity 
is necessary for the proper metabolism of insoluble carbo-
hydrates. This activity is required throughout multiple kingdoms 
and regulates an overlooked aspect of carbohydrate metabolism. 
It is striking that protists and plants have provided new insights 
into a human neurodegenerative disease involving aberrant carbo-
hydrate metabolism that was described almost 100 yr ago by 
Lafora and Gluck (Lafora, 1911; Lafora and Gluck, 1911).
Materials and methods
Cloning, vectors, and puriﬁ  cation of recombinant proteins
The complete open reading frame of Cm-laforin was cloned from cDNA 
provided by T. Kuroiwa (Rikkyo University, Tokyo, Japan) and SEX4 from 
SSP Consortium clone U14967 (Yamada et al., 2003). Cm-laforin and 
SEX4 were cloned into pET21a (Stratagene) according to standard proto-
cols. A second pET21a SEX4 construct was generated because the full-
length protein is largely insoluble. We truncated the ﬁ  rst 52 amino acids of 
SEX4 to generate pET21a ∆52-SEX4. pET21a VHR (Denu et al., 1995) 
and pET21a Hs-laforin (Wang et al., 2002) have been described previ-
ously. Hs-laforin, SEX4, and sex4-C198S were cloned in frame of a triple 
HA tag into pCHF1 (Neff et al., 1999), which is a modiﬁ  ed version of 
pPZP221 (Hajdukiewicz et al., 1994). pCHF1 contains the 35S cauli-
ﬂ  ower mosaic virus promoter, the Rubisco terminator from pea, and confers 
gentamicin resistance for selection in plants. Because Kerk et al. (2006) 
and Niittyla et al. (2006) demonstrated that the cTP of SEX4 targets SEX4 
to the chloroplast, we fused the cTP of SEX4 (nucleotides 1–213) in frame 
with Hs-laforin and the triple HA tag in pCHF to generate pCHF cTP–Hs-
laforin. All point mutations were generated with the QuikChange Site-
Directed Mutagenesis kit (Stratagene) according to the manufacturer’s 
instructions. All constructs were veriﬁ  ed by DNA sequencing. Recombinant 
proteins were expressed with a carboxy-terminal six-histidine tag in Esche-
richia coli BL21 (DE3) CodonPlus cells (Stratagene). Fusion proteins were 
expressed and puriﬁ  ed from soluble bacterial extracts using Ni
2+-agarose 
afﬁ  nity chromatography as described previously (Gentry et al., 2005).
Phosphatase assays
Hydrolysis of p-NPP was performed in 50-μl reactions containing 1× phos-
phate buffer (0.1 M sodium acetate, 0.05 M bis-Tris, 0.05 M Tris-HCl, and 
2 mM DTT at the appropriate pH), 50 mM pNPP, and 100–500 ng of 
enzyme at 37°C for 1–5 min. The reaction was terminated by the addition 
of 200 μl of 0.25 M NaOH, and absorbance was measured at 410 nm. We 
tested the speciﬁ  c activity of each enzyme at pH 5.0, 5.5, 6.0, 6.5, 7.0, 
7.5, and 8.0. The optimal pH for each enzyme was as follows: Hs-laforin, 
pH 5.0; Cm-laforin, pH 5.5; SEX4, pH 6.0; and VHR, pH 6.0. Malachite 
green assays were performed as described previously (Harder et al., 
1994) with the following modiﬁ  cations: 1× phosphate buffer, 100–500 ng 
of enzyme, and  45 μg of amylopectin in a ﬁ  nal volume of 20 μl. The re-
action was stopped by the addition of 20 μl of 0.1 M N-ethylmaleimide 
and 80 μl of malachite green reagent. Absorbance was measured at 620 nm. 
We tested the speciﬁ  c activity of each enzyme at the same pH units as 
above. The optimal pH for each enzyme was as follows: Hs-laforin, pH 7.0; 
Cm-laforin, pH 6.0; and SEX4, pH 8.0.
Phylogenetic analyses and sequence alignment
The sequences of laforin and SEX4 orthologues were obtained by perform-
ing tBLASTn searches using the GenBank dbEST database or BLASTp and 
PSI-BLAST (Altschul et al., 1997) searches using GenBank eukaryote 
genome and nr databases, the C. merolae genome project, Department 
of Energy Joint Genome Institute Resource, The Institute for Genomic 
Research, ToxoDB, GeneDB, Genoscope, and Tetrahymena Genome Data-
base. Accession numbers are listed in Tables S2 and S5 (available at 
http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). The web 
address for each database is listed in Table S1. A list of each genome that 
we investigated and a reason why an organism’s genome lacks laforin is 
listed in Table S4. Amino acid sequences of laforin orthologues were 
aligned by ClustalW (Thompson et al., 1994) and reﬁ  ned manually using 
MacVector. Small subunit ribosomal RNA sequences were obtained by 
performing BLASTn using GenBank from all organisms and nr databases, 
and accession numbers are listed in Table S3. The phylogenetic tree was 
generated from a ClustalW (Thompson et al., 1994) multiple sequence 
alignment using PROTDIST and FITCH from the PHYLIP 3.65 software pack-
age and was displayed using HYPERTREE 1.0.0 (Pﬁ  zer; Bingham and 
Sudarsanam, 2000).
Plant material
Homozygous sex4-3 plants (T-DNA insertion line SALK_102567; Alonso 
et al., 2003) were isolated by PCR. Stable transgenic plant lines were gener-
ated by Agrobacterium-mediated ﬂ  oral dipping (Clough and Bent, 1998), 
and seeds were sterilized, plated on standard growth medium (Valvekens 
et al., 1988), and selected for using 100 μg/ml gentamycin per standard 
protocols (Valvekens et al., 1988; Clough and Bent, 1998). Plants were 
grown in Promix-HP soil at 22°C with supplemental lighting conditions 
of 16-h days. To stain starch in leaves, leaves were decolorized in 80% 
(vol/vol) ethanol, stained with an iodine solution, and destained in water. 
Starch content was quantiﬁ  ed as previously described (Kotting et al., 
2005). mRNA was obtained using an RNeasy Plant Mini kit (QIAGEN), 
and ﬁ  rst-strand synthesis was performed using SuperScript III First-Strand 
Synthesis SuperMix (Invitrogen) according to the manufacture’s recommen-
dations. Four primer sets were used to test for the presence of transcripts in 
wild-type (Columbia) and sex4-3 plants. Three primer sets to the SEX4 tran-
script and a positive control to UBC5, the UBC5 primer set, was included 
in each PCR tube. Plant whole leaf lysate was obtained as described previ-
ously (Nimchuk et al., 2000).
Antibodies and Western analysis
The α–Hs-laforin and α–Cm-laforin antibodies were generated by immuniz-
ing rabbits with recombinant Hs-laforin or α–Cm-laforin, and antibodies 
were afﬁ  nity puriﬁ  ed from the serum with a HiTrap NHS-activated HP afﬁ  nity 
column (GE Healthcare) of Hs-laforin or Cm-laforin protein, respectively. The 
α–Cm-laforin antibody was generated in a similar manner. Recombinant Hs-
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followed by goat α–rabbit HRP (GE Healthcare). Recombinant VHR and 
SEX4 were detected with α-HIS-HRP (Santa Cruz Biotechnology, Inc.). Protein 
expression of A. thaliana transgenes was monitored by Western analysis 
using rat anti-HA (clone 3F10; Roche) and goat α–rat HRP (Chemicon).
C. merolae cell culture, immunoﬂ  uorescence, and immunogold 
electron microscopy
C. merolae 10D-14 (Toda et al., 1998) was provided by T. Kuroiwa and 
grown asynchronously at pH 2.5 in 2× Allens’s medium at 42°C under 
continuous illumination as described previously (Minoda et al., 2004). For 
immunoﬂ  uorescence, cells were ﬁ  xed, washed, and blocked as previously 
described (Nishida et al., 2004). Cells were then probed with 1:100 pre-
immune serum or 1:1,000 α–Cm-laforin antibody followed by 1:1,000 
AlexaFluor488 goat α–rabbit antibody (Invitrogen). Chloroplasts were 
visualized by their autoﬂ  uorescence. Immunoﬂ  uorescence was performed 
using a light microscope (DMR; Leica) with a PL APO 63× 1.32 NA oil ob-
jective (Leica) at room temperature, and images were captured with a CCD 
camera (C4742-95; Hamamatsu) using OpenLab 4.0.1 software (Improvi-
sion). For immunogold EM, cells were ﬁ  xed, washed, sectioned, and blocked 
as previously described (Nishida et al., 2003). Sections were immuno-
stained with 1:50 preimmune serum or 1:250 α–Cm-laforin antibody and 
with 10 nm of gold particle–conjugated goat α–rabbit antibody. Grids 
were viewed using a transmission electron microscope (1200EX II; JEOL), 
and images were collected using a digital camera (ORIUS SC600; Gatan) 
and Digital Micrograph software (Gatan). Photoshop (Adobe) and Illustra-
tor (Adobe) were used to generate ﬁ  gures of all images.
Online supplemental material
Fig. S1 shows puriﬁ  ed recombinant Cm-laforin and SEX4. Fig. S2 shows 
the phosphatase activity of Cm-laforin mutants using p-NPP and amylopec-
tin as substrates. Fig. S3 shows immuno-EM of a C. merolae cell probed 
with the secondary antibody alone. Fig. S4 shows the phosphatase activity 
of SEX4 mutants using p-NPP and amylopectin as substrates. Fig. S5 shows 
the quantitation of starch in wild-type, sex4-3, and transgenic plants. 
Table S1 provides data about non-NCBI databases, Table S2 provides 
accession numbers for laforin orthologues, and Table S3 provides small 
subunit ribosomal RNA accession numbers. Table S4 provides data about 
the genomes investigated for the presence of laforin, and Table S5 pro-
vides accession numbers for AMPKβ-GBD proteins and SEX4 orthologues. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200704094/DC1.
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